A carregar...
Severe piperacillin–tazobactam‐induced hemolysis in a cystic fibrosis patient
Piperacillin–tazobactam is one of the most common causes of drug‐induced immune hemolytic anemia (DIIHA) and is frequently utilized, especially in patients with cystic fibrosis (CF). Here, we report a case of life‐threatening piperacillin–tazobactam‐associated DIIHA in a 30‐year‐old woman with CF an...
Na minha lista:
Publicado no: | Clin Case Rep |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5715418/ https://ncbi.nlm.nih.gov/pubmed/29225856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1256 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|